A Gutsy Technical Call on a Biotech ETF
March 27, 2014 at 10:00 AM EDT
On Wednesday, the technical outlook for the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) was highlighted and the prognosis can easily be summed up: IBB was still honoring its multi-year uptrend, but it and the other biotech ETFs are in precarious technical positions. IBB, the largest biotech...